Search Volume Trend
NantBio, also known as NantBioscience, Inc., was a biopharmaceutical company focused on the discovery and development of molecularly targeted drugs to treat cancer, infectious diseases, and inflammatory diseases. The company aimed to develop treatments based on the molecular profile of a patient's tumor. NantBio was part of the NantWorks ecosystem and in March 2021, merged with ImmunityBio, Inc. to operate as ImmunityBio, Inc.
Growth Comparison
12 months
-82%
2 years
-112%
4 years
-96%